EPS HEALTH TECH (03860) issues profit warning, expects interim after-tax loss to increase by approximately HK$8 million to approximately HK$12 million

EPS HEALTH TECH (03860) has issued an announcement that the Group expects to record an increase in after-tax loss of approximately HK$8 million to approximately HK$12 million for the six months ended 30 September 2026 compared with the corresponding period in 2025. The expected increase in loss for the current period compared with the corresponding period in 2025 was primarily due to a decline in revenue from the IRO and CRO services business as a result of very intense market competition, as well as a decrease in gross profit from the healthcare products and pharmaceutical business affected by rising procurement costs and clearance of low-priced inventory. During the current period, given the challenging market environment, the Group also expects the apparel business to record a segment loss of approximately HK$2 million, which is comparable to the corresponding period in 2025.